Promethazine With Codeine Oral Solution Recall Due to Microbial Contamination
Morton Grove Pharmaceuticals is recalling Promethazine With Codeine Oral Solution (Lot #UV1198) nationwide due to potential microbial contamination in liquid sugar batches used during manufacturing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The source states a CGMP deviation involving potential microbial contamination in a liquid sugar ingredient used to manufacture an oral pharmaceutical product. This represents a risk-of-harm concern for contaminated drug products. The source text does not report any confirmed illnesses or injuries, making this a theoretical hazard that does not qualify as Severe (score 4) but warrants a High rating due to the nature of microbial contamination in a drug intended for internal use.
Plain-English summary
Morton Grove Pharmaceuticals, Inc. is recalling Promethazine With Codeine Oral Solution containing Promethazine Hydrochloride 6.25 mg/5mL and Codeine Phosphate 10 mg/5 mL in 1-pint (473 mL) bottles (NDC: 60432-606-16, Lot #UV1198). The product was manufactured for Wockhardt USA, LLC.
The recall is being issued due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, there is a potential concern that products were manufactured using liquid sugar batches contaminated with microbial organisms.
Approximately 14,904 bottles have been distributed nationwide in the USA and to China. This is a prescription-only medication. Consumers who have this product should contact their pharmacy or healthcare provider for guidance on whether they have affected units.
The recalled product
- Product
- Promethazine With Codeine Oral Solution, (Promethazine Hydrochloride 6.25 mg/5mL & Codeine Phosphate 10 mg/5 mL), 1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC:
- Manufacturer
- Morton Grove Pharmaceuticals, Inc.
- Hazard
- microbial-contamination
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: UV1198
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27